V
VM Discovery
Drug design and optimization technology platform
About VM Discovery
VM Discovery, Inc. was a drug design and discovery company founded in 2001 and headquartered in Fremont, California. The firm focused on developing a drug design and optimization technology to identify multi-property optimized drug candidates for pharmaceutical and biotechnology partners.
The company's core technology, VMOptimizer, was a multivariate drug design platform. It conducted parallel multi-property modeling, optimization, and virtual screening to select small molecule drug candidates with balanced potency. The objective was to enable the production of new medicines more quickly and with fewer resources. The company's business model involved collaborating with pharmaceutical and biotech companies to provide internally optimized drug candidates.
Throughout its history, VM Discovery secured funding from various sources, including venture capital and grants from institutions like the National Cancer Institute. Investors included ONSET Ventures and Amkey Ventures. In June 2012, the company spun out a novel ion channel blocker program into a new entity, VM Therapeutics, which secured $8 million in venture funding. According to PitchBook, VM Discovery ceased operations as of July 2021.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Jul 2014 | $13M | $50M | Undisclosed | — |
| SERIES B✓Equity / VC | Jan 2006 | $970K | $3.9M | Amkey Ventures · Onset Ventures | — |
Growth signals
Latest recorded traffic for VM Discovery is 110 monthly website visits. VM Discovery's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 XuvenlabScientific experimentation kits for secondary education |
Las Palmas de Gran Canaria, Spain | Operational | — | — | — |
 MakbyComprehensive 3D bioprinting solutions integrating diverse technologies and biomaterials for seamless workflow control |
San Sebastián, Spain | Operational | |||
 FourPlusImmersive VR and AR training for life sciences |
United Kingdom | Operational | |||
 8chiliVR Platform for Training and Education |
San Ramon, United States | Operational | |||
 Cape BionicsCape brings the world's most advanced compression technology from the aerospace and medical industries to professional sports |
Melbourne, Australia | Operational | |||
 3D-neuro3D-printed gear for systems neuroscience |
Nijmegen, Netherlands | Operational | |||
 AmarisAmaris International Consulting Company |
Geneva, Switzerland | Operational | |||
 UpSurgeOnEmpower the learning and teaching methods for Neuroanatomy and Neurosurgery |
Milan, Italy | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- AVAmkey Ventures
- OVOnset Ventures
Other known investors1 additional known investor
GRC SinoGreen Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about VM Discovery on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See VM Discovery’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.